These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28510519)

  • 1. Health Insurers Often Foot Bill When Drug Coupons Are Used.
    Wolinsky H
    Manag Care; 2017 Mar; 26(3):38-39. PubMed ID: 28510519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
    Nemlekar P; Shepherd M; Lawson K; Rush S
    J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums.
    Starner CI; Alexander GC; Bowen K; Qiu Y; Wickersham PJ; Gleason PP
    Health Aff (Millwood); 2014 Oct; 33(10):1761-9. PubMed ID: 25288420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs.
    Gastala NM; Wingrove P; Gaglioti A; Petterson S; Bazemore A
    Health Aff (Millwood); 2016 Jul; 35(7):1237-40. PubMed ID: 27385239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions.
    Doshi JA; Li P; Ladage VP; Pettit AR; Taylor EA
    Am J Manag Care; 2016 Mar; 22(3):188-97. PubMed ID: 27023024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pharmaceutical rebates on patients' drug expenditures.
    Memedovich KA; Manns B; Beall R; Hollis A; Clement F
    CMAJ; 2019 Mar; 191(11):E308-E312. PubMed ID: 30885969
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?
    Sarnak DO; Squires D; Kuzmak G; Bishop S
    Issue Brief (Commonw Fund); 2017 Oct; 2017():1-14. PubMed ID: 28990747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription drug accessibility and affordability in the United States and abroad.
    Morgan S; Kennedy J
    Issue Brief (Commonw Fund); 2010 Jun; 89():1-12. PubMed ID: 20614652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copayment coupons undermine formularies.
    Manag Care; 2011 Dec; 20(12):63. PubMed ID: 22259878
    [No Abstract]   [Full Text] [Related]  

  • 11. Specialty pharmaceuticals: policy initiatives to improve assessment, pricing, prescription, and use.
    Robinson JC; Howell S
    Health Aff (Millwood); 2014 Oct; 33(10):1745-50. PubMed ID: 25288418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Share Of Specialty Drugs In Commercial Plans Nearly Quadrupled, 2003-14.
    Dusetzina SB
    Health Aff (Millwood); 2016 Jul; 35(7):1241-6. PubMed ID: 27385240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons why insured consumers co-pay for medicines at retail pharmacies in Pretoria, South Africa.
    Mpanza NM; Bradley H; Laing R
    Afr J Prim Health Care Fam Med; 2019 Mar; 11(1):e1-e6. PubMed ID: 31038333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT; Barnes J; Shea T; Coulter SL
    J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare Part D update--lessons learned and unfinished business.
    Neuman P; Cubanski J
    N Engl J Med; 2009 Jul; 361(4):406-14. PubMed ID: 19625722
    [No Abstract]   [Full Text] [Related]  

  • 17. Health benefits in 2014: stability in premiums and coverage for employer-sponsored plans.
    Claxton G; Rae M; Panchal N; Whitmore H; Damico A; Kenward K
    Health Aff (Millwood); 2014 Oct; 33(10):1851-60. PubMed ID: 25214470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Sharing, Health Care Expenditures, and Utilization: An International Comparison.
    Perkowski P; Rodberg L
    Int J Health Serv; 2016; 46(1):106-23. PubMed ID: 26545706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy initiatives target prescription drug costs.
    Stafford E
    J Mich Dent Assoc; 2008 Sep; 90(9):22. PubMed ID: 19051519
    [No Abstract]   [Full Text] [Related]  

  • 20. The Impact of Pharmacy Benefit Managers on Drug Pricing.
    Patel DJ; Bhatia N; Kaufmann MD
    J Drugs Dermatol; 2020 Sep; 19(9):900-903. PubMed ID: 33026747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.